A brief introduction of Bentham Science Brand Ambassador:
Bentham Science Ambassador Program, a project of Bentham Science, is an effort to liaison between the researcher and the publisher. This program will act as a tool to spread information and knowledge about Bentham content and initiatives among the research community. Through promoting Bentham Science content, the Bentham Science Ambassador encourages researchers to contribute to Bentham Science publications, and will in return be rewarded points for the tasks performed by them, which they could redeem through various offers & incentives by Bentham Science such as, Bentham Science eBooks, Open Access Journal, etc. This online portal will facilitate the ambassadors in performing their tasks.
Dr. Gross received a masters (M.S.) in Biology from the California State University and his doctorate (Ph.D.) in Cell Biology from the University of California, Los Angeles. He did his postdoctoral training at Tulane University School of Medicine. He has also done postgraduate programs at the Wharton School, Harvard/Tufts Law Schools and MIT. Dr. Gross is also faculty in the Jefferson College of Biomedical Sciences and the Sydney Kimmel Medical College of Thomas Jefferson University, Professor of Experimental Therapeutics and Medicinal Chemistry in the Blumberg Institute and Adjunct Professor of Basic Sciences at The Commonwealth Medical College. He has published more than 120 scientific publications. He currently is also the CEO of the Pennsylvania Drug Discovery Institute.
Chad E. Beyer Promentis Pharmaceuticals Milwaukee, WI (USA)
Dr. Beyer is President & CEO of Promentis Pharmaceuticals, Inc. He has nearly 20 years of experience in the research, discovery and business development of medications aimed to treat CNS and neurological disorders. Previously, Dr. Beyer served as the Head of Neurochemistry at Wyeth Pharmaceuticals in Princeton, NJ. During his career at Wyeth, Dr. Beyer holds a Ph.D. in Neuropharmacology from LSU Medical Center and an MBA from the Rutgers Business School. Notably, Dr. Beyer has authored more than 70 manuscripts, 3 patents, and co-edited "Next Generation Antidepressants." Dr. Beyer is also an adjunct faculty member at Thomas Jefferson University in Philadelphia where he teaches "Bioventure Management", a class focused on the business of doing science.